Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON45475Phase 4Completed
Phase 4, open-label trial of posaconazole in invasive mycoses and aspergillosis (3 arms), sponsored by Radboud University Medical Center. Primary endpoints: Population pharmacokinetic model, Model validation and 1 more. Started Nov 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON45475.